European lockdowns worry investors, China’s Five-Year plan

European lockdowns worry investors, China’s F...

Up next

The Bethlehem Project: Voters feel anxious and uncertain as US midterms near

The FT sat down with more than a dozen voters in Bethlehem, Pennsylvania, ahead of next week’s midterm elections. The roundtable discussion showed that some are staunch supporters of President Donald Trump and some feel a bit more on the fence. But it seems almost all of them fee ...  Show more

Martin Wolf on the US midterms: What’s at stake for the world?

As Americans prepare to vote in the November 3 midterm elections, FT chief economics commentator Martin Wolf asks what the result will mean for Donald Trump, the future of US democracy and America's place in the world. In the second of a six-part series of interviews with leading ...  Show more

Recommended Episodes

Stocks sink more than 2,000 points, Italy goes on lockdown and a total of 5 U.S. congressmen self-quarantine
Anderson Cooper 360

The stock market continues to fall as worries about the coronavirus and ripple effects impact the global economy. Richard Quest, CNN Business Editor at Large and Alexis Click, a financial expert, join AC360° to discuss how unstable the market is right now and what to expect in th ...  Show more

World on lockdown, markets melt, hospitals suffer
FT News in Focus

The FT News Briefing is a rundown of the global business stories you need to know for the coming day, from the newsroom of the Financial Times. If you enjoy it, subscribe to the FT News Briefing wherever you get your podcasts, or listen at FT.com/newsbriefing.Tuesday, March 17Gov ...  Show more

Market Reaction to COVID Lockdowns and Developments, a Record High for the Nasdaq, The EV Space’s Week for the Ages and the House Passes Pres. Biden's $1.7T Social Spending Package
Squawk on the Street

Carl Quintanilla, Jim Cramer and David Faber discussed market worries about COVID-19, with Austria announcing a nationwide lockdown while Germany tried to tamp down fears that it would follow suit. But in the U.S., FDA authorized use of Pfizer and Moderna's COVID vaccine booster ...  Show more